D-Index & Metrics Best Publications

Bayard L. Powell

Wake Forest University
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 77 Citations 31,256 383 World Ranking 13154 National Ranking 6839

Overview

What is he best known for?

The fields of study Bayard L. Powell is best known for:

Cancer
Chemotherapy
Gene

His research on Internal medicine frequently connects to adjacent areas such as Daunorubicin. In his work, Bayard L. Powell performs multidisciplinary research in Leukemia and Chemotherapy. He brings together Chemotherapy and Leukemia to produce work in his papers. His study deals with a combination of Myeloid leukemia and Acute leukemia. He combines Acute leukemia and Myeloid leukemia in his research. Bayard L. Powell performs integrative study on Oncology and Gastroenterology. In his work, Bayard L. Powell performs multidisciplinary research in Gastroenterology and Oncology. Bayard L. Powell applies his multidisciplinary studies on Gene and Biochemistry in his research. He conducts interdisciplinary study in the fields of Biochemistry and Gene through his research.

His most cited work include:

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia (3138 citations)
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B (1615 citations)
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study (676 citations)

What are the main themes of his work throughout his whole career to date

His research is interdisciplinary, bridging the disciplines of Myeloid and Internal medicine. In his research, he performs multidisciplinary study on Myeloid and Leukemia. His study deals with a combination of Leukemia and Cancer. His research is interdisciplinary, bridging the disciplines of Internal medicine and Cancer. His research ties Immunology and Myeloid leukemia together. While working on this project, Bayard L. Powell studies both Immunology and Genetics. Bayard L. Powell incorporates Genetics and Cancer research in his research. His Cancer research study frequently involves adjacent topics like Myeloid leukemia. In his articles, Bayard L. Powell combines various disciplines, including Oncology and Gastroenterology.

Bayard L. Powell most often published in these fields:

Internal medicine (93.45%)
Leukemia (63.69%)
Myeloid leukemia (58.93%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Brian J. Druker;François Guilhot;Stephen G. O'brien;Insa Gathmann.
The New England Journal of Medicine (2006)

4139 Citations

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Lewis R. Silverman;Erin P. Demakos;Bercedis L. Peterson;Alice B. Kornblith.
Journal of Clinical Oncology (2002)

2085 Citations

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

Mayer Rj;Davis Rb;Schiffer Ca;Berg Dt.
The New England Journal of Medicine (1994)

2031 Citations

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Alan List;Gordon Dewald;John Bennett;Aristotle Giagounidis.
The New England Journal of Medicine (2006)

1718 Citations

IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Guido Marcucci;Kati Maharry;Yue-Zhong Wu;Michael D. Radmacher.
Journal of Clinical Oncology (2010)

857 Citations

Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

Charles A. Schiffer;Kenneth C. Anderson;Charles L. Bennett;Steven Bernstein.
Journal of Clinical Oncology (2001)

773 Citations

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

R. Coleman Lindsley;Brenton G. Mar;Emanuele Mazzola;Peter V. Grauman.
Blood (2015)

718 Citations

Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia

Richard M. Stone;Deborah T. Berg;Stephen L. George;Richard K. Dodge.
The New England Journal of Medicine (1995)

648 Citations

Impact of Azacytidine on the Quality of Life of Patients With Myelodysplastic Syndrome Treated in a Randomized Phase III Trial: A Cancer and Leukemia Group B Study

Alice B. Kornblith;James E. Herndon;Lewis R. Silverman;Erin P. Demakos.
Journal of Clinical Oncology (2002)

571 Citations

MicroRNA expression in cytogenetically normal acute myeloid leukemia

Guido Marcucci;Michael D. Radmacher;Michael D. Radmacher;Kati Maharry;Kati Maharry;Krzysztof Mrózek.
The New England Journal of Medicine (2008)

521 Citations

If you think any of the details on this page are incorrect, let us know.